SCHEMBL2991387

SCHEMBL2991387

Cc1cccc2[nH]c3ccccc3c12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.62
MAPT P10636 1/20 0.62
KMT2A Q03164 1/20 0.62
GABRP O00591 3/20 0.61
GABRD O14764 3/20 0.61
GABRA1 P14867 3/20 0.61
GABRB1 P18505 3/20 0.61
GABRG2 P18507 3/20 0.61
GABRB3 P28472 3/20 0.61
GABRA5 P31644 3/20 0.61
GABRA3 P34903 3/20 0.61
GABRA2 P47869 3/20 0.61
GABRB2 P47870 3/20 0.61
GABRA4 P48169 3/20 0.61
GABRE P78334 3/20 0.61
GABRA6 Q16445 3/20 0.61
GABRG1 Q8N1C3 3/20 0.61
GABRG3 Q99928 3/20 0.61
GABRQ Q9UN88 3/20 0.61
KIF11 P52732 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30573128 1.00 MEN1 (0.62) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL29150376 0.98 MAPT (0.60) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL22045026 0.90 GABRP (0.56) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL28479370 0.85 GABRP (0.52) MEN1MAPTKMT2AGABRPGABRD
Boric Acid SCHEMBL29150382 0.85 GABRP (0.49) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL18926341 0.84 GABRP (0.55) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL20934479 0.84 KIF11 (0.56) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL11032998 0.84 ABCG2 (0.63) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL6008331 0.84 GPR84 (0.48) MEN1MAPTKMT2AGABRPGABRD
SCHEMBL30715250 0.84 GPR84 (0.48) MEN1MAPTKMT2AGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112920113-A Beta amyloid-targeted fluorescent probe, preparation method thereof and application thereof in Alzheimer's disease 华南理工大学 2021-06-08 CN claimed
CN-107935913-A Carbazole compound and its synthetic method and application 华东师范大学 2018-04-20 CN claimed
WO-2017160361-A1 POLYISOCYANURATE CATALYSTS FOR METAL PANELS AND SPRAY FOAMS HUNTSMAN PETROCHEMICAL LLC (US) 2017-09-21 WO claimed
EP-2925139-B1 FERMENTED SOIL ADDITIVE LIQUID FERTILISER SYSTEMS PTY LTD (AU) 2025-04-30 EP disclosed
CN-114685353-B Organic compound for organic light-emitting device and organic electroluminescent device 北京鼎材科技有限公司 2025-04-08 CN disclosed
CN-118772175-A Fused ring compound and application thereof 华南理工大学 2024-10-15 CN disclosed
CN-113710654-B Polymerizable liquid crystal having carbazole nucleus 罗利克技术有限公司 2024-08-30 CN disclosed
US-12048242-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-23 US disclosed
US-20240244856-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC APPARATUS, AND PRODUCTION METHOD FOR ORGANIC ELECTROLUMINESCENCE ELEMENT IDEMITSU KOSAN CO.,LTD. (JP) 2024-07-18 US disclosed
WO-2024142108-A1 Π-EXTENDED HELICAL NANOGRAPHENES AND THE USE THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) 2024-07-04 WO disclosed
US-12029109-B2 Light emitting diode and amine compound for the same SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-02 US disclosed
EP-0520012-A1 IMPROVED MULTIFUNCTIONAL VISCOSITY INDEX IMPROVER-DISPERSANT ANTIOXIDANT (PT-789). EXXON CHEMICAL PATENTS INC (US) 1992-12-30 EP disclosed
EP-0518949-A1 NOVEL HETEROCYCLIC NITROGEN COMPOUND MANNICH BASE DERIVATIVES OF AMINO-SUBSTITUTED POLYMERS FOR OLEAGINOUS COMPOSITIONS. EXXON CHEMICAL PATENTS INC (US) 1992-12-23 EP disclosed
WO-1991013954-A1 NOVEL HETEROCYCLIC NITROGEN COMPOUND MANNICH BASE DERIVATIVES OF AMINO-SUBSTITUTED POLYMERS FOR OLEAGINOUS COMPOSITIONS EXXON CHEMICAL PATENTS INC. (US) 1991-09-19 WO disclosed
WO-1991013952-A1 IMPROVED MULTIFUNCTIONAL VISCOSITY INDEX IMPROVER-DISPERSANT ANTIOXIDANT (PT-789) EXXON CHEMICAL PATENTS INC. (US) 1991-09-19 WO disclosed
US-4758639-A Process for production of vinyl polymer SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-19 US disclosed
US-4757124-A Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-12 US disclosed
EP-0172427-A2 Process for production of vinyl chloride polymer Shin-Etsu Chemical Co., Ltd. (JP) 1986-02-26 EP disclosed
US-4539230-A COATING WALLS WITH A CHELATE COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 1985-09-03 US disclosed
EP-0126991-A1 A method for preventing deposition of polymer scale and a coating agent therefor Shin-Etsu Chemical Co., Ltd. (JP) 1984-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12048242-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device RER1, LEF1, MLX MEN1 654/4885MAPT 3442/4885KMT2A 1826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.